Articles On Eagle Health Holdings (ASX:EHH)
Title | Source | Codes | Date |
---|---|---|---|
Millionaire maker increases share price 28 times in FY20
Zoono Group Ltd (ASX: ZNO) has seen more explosive share price growth than any company on the S&P/ASX All Ordinaries (INDEXASX: XGD) in FY20. In one financial year, it has grown by more than 2,788%! Dreams are made of this stuff. It’s... |
Motley Fool | EHH | 4 years ago |
Zoono inks sanitiser deal with Johns Lyng Group
Biotech company Zoono Group (ASX: ZNO) has clinched an exclusive deal with Australian builder Johns Lyng Group (ASX: JLG) for the distribution of sanitisers that have tested 99.99% effective against a COVID-19 surrogate virus. The exclusive... |
SmallCaps | EHH | 4 years ago |
Will The Listed Sanitiser Stocks Clean Up – Or Clean Out – Investors?
ShareCafeWill The Listed Sanitiser Stocks Clean Up – Or Clean Out – Investors? Who said capitalism was dead in the new world order of prolific government handouts? The profit motive is at least alive and kicking in the sexed-up sanitiser se... |
ShareCafe | EHH | 4 years ago |
Hand Sanitisers: Clean Up Or Clean Out?
By Tim Boreham, Editor, The New Criterion Will the listed sanitiser stocks clean up – or clean out – investors? Who said capitalism was dead in the new world order of prolific government handouts? The profit motive is at least alive and kic... |
FNArena | EHH | 4 years ago |
“Your Stock Request” – 2 April 2020
“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o... |
Fairmont Equities | EHH | 4 years ago |
Coronavirus spurs China’s appetite for our tea tree oil, hand sanitiser, honey, medicine, technology
Promising green shoots are appearing amid tumbling stocks as China reaches out to Australian producers amid the coronavirus outbreak. While it’s doom and gloom in Australia’s retail sector, it’s a different story in some of the smaller sto... |
Stockhead | EHH | 4 years ago |
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus
As with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time attaching itself to the ‘c’ word. We’re talking of course about the coronavirus COVID-19 but sadly not another ‘c’ word: cure. Or not yet. Accor... |
Stockhead | EHH | 4 years ago |
Why this small-cap ASX healthcare share surged 24% today
The Eagle Health Holdings Ltd (ASX: EHH) share price opened 24.32% higher this morning following the announcement it is expanding production of disposable medical masks. New production lines are being added at the company’s facility in Xi... |
Motley Fool | EHH | 4 years ago |
Eagle Health expands disposable mask manufacturing in China amid COVID-19 pandemic
Amid the worsening COVID-19 pandemic, integrated health and nutritional products business Eagle Health (ASX: EHH) has announced expanded production of disposable medical masks at its pharmaceutical facility in Xiamen, China. The first two o... |
SmallCaps | EHH | 4 years ago |
These ASX shares are fighting the spread of coronavirus
The spread of coronavirus has infected global share markets with the contagion of fear. The S&P/ASX 200 Index (INDEXASX: XJO) has fallen more than 10% in the last fortnight as investors flee to safe havens. This week, the Reserve Bank... |
Motley Fool | EHH | 4 years ago |
Corporate: Eagle Health pounces on another coronavirus opportunity
Businesses will take any opportunity to cash in on a crisis and the latest move to profit from the coronavirus outbreak has been made by dietary supplement maker Eagle Health Holdings (ASX:EHH). After announcing it was partnering up with Zo... |
Stockhead | EHH | 4 years ago |
Eagle Health Holdings (ASX:EHH) expands manufacturing in China for masks
06 Mar 2020 - Eagle Health Holdings (ASX:EHH) has expanded its production facilities at its wholly owned GMP pharmaceutical facility in Xiamen China for the production of disposabl… |
FNN | EHH | 4 years ago |
Check up: Biotechs are sinking on pandemic fears
Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks, 112 saw their share prices fall, 17 improved and eight were flat. Code Name Price $ (March 3) 2 week return %... |
Stockhead | EHH | 4 years ago |
Why the Zoono share price has skyrocketed 250% in 2020
ASX shares have been sent tumbling in recent weeks as the economic impacts of the coronavirus outbreak have been felt across the world. However, it hasn’t been doom and gloom for everyone on the ASX. Shares in New Zealand-based biotech com... |
Motley Fool | EHH | 4 years ago |
February Winners Column: Wannabe virus fighters ride high in a rough month for stocks
In February, mounting coronavirus-led uncertainty finally culminated in a late-month share price bloodbath. After a 3 per cent gain in January, the S&P/ASX Emerging Companies Index – which gauges the health of the microcap sector – had... |
Stockhead | EHH | 4 years ago |
Why the Zoono share price rocketed another 19% higher today
The Zoono Group Ltd (ASX: ZNO) share price rocketed another 19.26% today to close at $2.26. This follows what appears to be further positive upwards market momentum following two ASX announcements made last Friday. The first announcement w... |
Motley Fool | EHH | 4 years ago |
It’s not just hand sanitisers, these 3 micro-sectors have been winners during the coronavirus crisis
The coronavirus has been troubling markets for much of the year and has sent them tumbling this week as its spread abroad becomes more serious. The biggest coronavirus-panic-fuelled share price gains have come from antimicrobial solution ma... |
Stockhead | EHH | 4 years ago |
When your guts have gone nuts, who do you call? These ASX stocks are fighting gastrointestinal disease
Gastrointestinal diseases are among the most inconvenient types of illnesses to have, and not just because they may have you running to the loo every five minutes. The field covers many diseases like Irritable Bowel Syndrome (IBS), Crohn’s... |
Stockhead | EHH | 4 years ago |
Coronavirus fears send tourism and China-focused consumer stocks plunging
It’s a bleak morning for ASX stocks in the tourism and China-focused sectors. A contravirus began in the Chinese city of Wuhan and while the city is now in lockdown mode, about 5 million people left beforehand due to the Lunar New Year holi... |
Stockhead | EHH | 4 years ago |
10 at 10: These ASX stocks are getting ahead this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | EHH | 5 years ago |
Rise & Shine: What you need to know before the ASX opens
On Stockhead today: five water treatment stocks surge 260 per cent in a year, the ASX’s most intriguing bargain barrel stocks, the five 2019 IPO stocks delivering triple returns and Dorado-3 oil flow gets Carnarvon on track. But first: Th... |
Stockhead | EHH | 5 years ago |
Top 10 at 10: These ASX stocks are motoring ahead this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | EHH | 5 years ago |
Corporate: GBST board will say ‘I do’ to SS&C’s marriage proposal
GBST Holdings has told shareholders this morning to accept the latest takeover bid from SS&C Technologies. SS&C has offered $3.60 per share, which is 82 per cent higher than when it first bid and 16 per cent higher than GBST’s last... |
Stockhead | EHH | 5 years ago |
Feeling chubby? Check out these obesity-blasting ASX stocks
Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any... |
Stockhead | EHH | 5 years ago |
Feeling chubby? Check out these obesity-blasting ASX stocks
Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any... |
Stockhead | EHH | 5 years ago |